Sharon Bio Medicine touches the roof on receiving EIR from USFDA for Taloja plant

20 Sep 2016 Evaluate

Sharon Bio-Medicine is currently trading at Rs. 10.16, up by 1.69 points or 19.95% from its previous closing of Rs. 8.47 on the BSE.

The scrip opened at Rs. 8.50 and has touched a high and low of Rs. 10.16 and Rs. 8.35 respectively. So far 315645 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 32.55 on 16-Dec-2015 and a 52 week low of Rs. 8.25 on 16-Sep-2016.

Last one week high and low of the scrip stood at Rs. 10.16 and Rs. 8.25 respectively. The current market cap of the company is Rs. 120.84 crore.

The promoters holding in the company stood at 52.26%, while institutions and non-institutions held 5.03% and 42.71% respectively.

Sharon Bio Medicine has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) conducted during period ranging from June 29, 2015 to July 7, 2015 at Active Pharmaceutical Ingredient (API) plant located at L-6, MIDC, Taloja, Dist. Raigad, Maharshtra. The API Plant now is approved by USFDA. The payment for Generic Drug User Fee (GDUFA Fees) is pending and therefore supply to the United States of America cannot be done unless pending arrears are cleared.

Sharon Bio-Medicine is into manufacturing and supply of Active Pharmaceutical Ingredients (APIs).

Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.